These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6653797)

  • 41. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk.
    Budai B; Számel I; Sulyok Z; Németh M; Bak M; Kralovánszky J; Ottó S; Besznyák I; Purohit A; Parish DC; Reed MJ
    Anticancer Res; 2000; 20(5C):3879-86. PubMed ID: 11268470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol.
    Colin C; Gaspard U; Lambotte R
    Arch Gynakol; 1978 Feb; 225(1):7-13. PubMed ID: 345994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of luteal phase inadequacy with bromocriptine.
    Saunders DM; Hunter JC; Haase HR; Wilson GR
    Obstet Gynecol; 1979 Mar; 53(3):287-9. PubMed ID: 424098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclic and diurnal patterns of serum prolactin in the Rhesus monkey.
    Quadri SK; Spies HG
    Biol Reprod; 1976 May; 14(4):495-501. PubMed ID: 819048
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Secretory changes in the plasma levels of prolactin, estradiol and progesterone during the normal menstrual cycle].
    Vulkov I; Maleeva A; Visheva N
    Akush Ginekol (Sofiia); 1977; 16(4):278-82. PubMed ID: 907065
    [No Abstract]   [Full Text] [Related]  

  • 48. Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast.
    Dogliotti L; Faggiuolo R; Ferusso A; Orlandi F; Sandrucci S; Tibo A; Angeli A
    Horm Res; 1985; 21(3):137-44. PubMed ID: 3922866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultradian (12-hr) significant component in serum prolactin of healthy women and patients with fibrocystic mastopathy.
    D'Allesandro B; Esposito V; Lo Iudice G; Cagnoni M; Tarquini B
    Prog Clin Biol Res; 1987; 227B():281-4. PubMed ID: 3628338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Benign breast diseases: hormonal studies in 125 cases (author's transl)].
    Mauvais-Jarvis P; Kuttenn F; Mowszowicz I; Sitruk-Ware R
    Nouv Presse Med; 1977 Dec; 6(44):4115-8. PubMed ID: 600762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endocrine evaluation of patients with benign lumps of the breast.
    Mancini A; di Pietro C; de Marinis L; Rossi S; Lombardi CP; Iacona T; Bellantone R; Liberale I; Menini E; Crucitti F
    Cancer Detect Prev; 1992; 16(1):27-30. PubMed ID: 1532347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sporadic and recurrent luteal phase defects in cyclic women: comparison with normal cycles.
    Aksel S
    Fertil Steril; 1980 Apr; 33(4):372-7. PubMed ID: 6767629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles].
    Kubista E; Müller G; Spona J
    Rev Fr Gynecol Obstet; 1987 Apr; 82(4):221-7. PubMed ID: 3589362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Luteal phase hyperprolactinemia.
    Falk RJ; Anderson L
    Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol.
    O'Brien PM; Abukhalil IE
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):18-23. PubMed ID: 9914571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomised controlled trial of medroxyprogesterone acetate in mastalgia.
    Maddox PR; Harrison BJ; Horobin JM; Walker K; Mansel RE; Preece PE; Nicholson RI
    Ann R Coll Surg Engl; 1990 Mar; 72(2):71-6. PubMed ID: 2139769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cimetidine and plasma levels of gonadotropins, prolactin and gonadal steroids in women.
    Bélisle S; Patry M; Tétreault L
    Can Med Assoc J; 1982 Jul; 127(1):29-32. PubMed ID: 6805933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F; Schuth W; Scheurich B; Breckwoldt M
    Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Midluteal immunoreactive alpha-inhibin serum concentrations as markers of luteal phase deficiency.
    Balasch J; Creus M; Fábregues F; Casamitjana R; Ordi J; Vanrell JA
    Hum Reprod; 1996 Dec; 11(12):2591-4. PubMed ID: 9021356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dehydrogesterone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency.
    Balasch J; Vanrell JA; Márquez M; Burzaco I; González-Merlo J
    Fertil Steril; 1982 Jun; 37(6):751-4. PubMed ID: 7084497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.